Albany, NY -- (SBWIRE) -- 02/13/2012 -- Global Coronary Stents market is estimated to be USD 6,013million in 2011 and expected to reach USD 8,292million in 2016 at a CAGR of 6.6% over the period 2010 to 2016. The Drug Eluting Stents (DES) segment is the leading market contributor with a share of around 55% – 60% in 2010.

Browse full report at Coronary Stents Market

With the high prevalence of cardiovascular diseases, the global coronary stent market is gaining every year experiencing a 6.6% CAGR growth.

Also, owing the growth in demand for minimally invasive procedures, these stents, especially drug eluting stents, are finding rapid increase in their market penetration of more than 60% approximately.

The drug eluting stents (DES) segment contributed 55%-60% of the global coronary stent market in 2010. The global DES segment is expected to reach USD 5.3 billion in 2016 after growing at a CAGR of 9.54% from 2011 to 2016.The biggest factor in the growth of this market is found in the aging populations in developed countries. Segmented by geographic regions, the market for Drug Eluting Stents (DES) is growing at 9.0% in the United States, at 3.1% in Europe, at 10% in Asia-Pacific and 3.1% in the rest of the world.

Browse: Bare Metal Stent Market
At present, the strongest area of growth is drug eluting stents – after the introduction of which the growth in bare-metal stents declined quickly.Increase in the elderly population, lifestyle changes leading to obesity and the advent of advanced technologies such as bio-absorbable and new generation stents are some of the major driving factors for the global coronary stent market.

The market for bare-metal stents (BMS) segment globally contributed around 40% to 45% of the global coronary stent market in 2010 and is expected to reach at a market size of USD 2.9 billion by 2016 growing at a rate of 2% CAGR during 2011 and 2016.Increase in the elderly population, lifestyle changes leading to obesity and the advent of advanced technologies such as bio-absorbable and new generation stents are some of the major driving factors for the global coronary stent market.

Browse: Drug Eluting Stent Market
Among the various markets across the globe, the U.S forms the largest market for Coronary stents followed by Europe, the Asia-Pacific region countries, Japan and China.The leading players in this market include Johnson & Johnson, Boston Scientific, Abbott Laboratories and Medtronics making up for the major share of the market worldwide.

Scope and Overview
The report covers all the major types of coronary stents – i.e. Drug Eluting Stents, Bare Metal Stents and Bio-Absorbable Stents. The report discusses the key influencing factors for the coronary stent market across the geographies. The report also includes an in-depth analysis of different sub-segments. The report estimates, forecasts the market sizes (2010-2016) and growth rates for different segments and geographies.

The report analyses the global trend of coronary stent market and discusses the rationale behind various industry moves. The report provides competitive scenario of this market and highlights major market going-on.An in-depth geographic analysis is conducted for each of the sub-segment in the major regional markets of Americas, Europe, Asia and ROW.The report also covers the strategies followed by “Global Drug Eluting, Bare-Metal and Other Coronary Stents Market“ players.

http://www.transparencymarketresearch.com/coronary-stents-market.html